Tenofovir Disoproxil · larger labeled portfolio than Ganciclovir
SPL labels Ganciclovir + Tenofovir Disoproxil as minor; Ganciclovir 7 / Tenofovir Disoproxil 13 in that band.
Mechanism on file: These drugs are both removed from the body by the kidneys, which can cause them to build up in your system.
FDA SPL severity: Minor
Tenofovir Disoproxil
Full Tenofovir Disoproxil label recordNucleotide Reverse Transcriptase Inhibitor
Ganciclovir + Tenofovir Disoproxil · SPL mechanism field
These drugs are both removed from the body by the kidneys, which can cause them to build up in your system.
Minor band excerpt · Ganciclovir with Tenofovir Disoproxil
Some examples include, but are not limited to, acyclovir, cidofovir, ganciclovir, valacyclovir, valganciclovir, aminoglycosides (e.g., gentamicin), and high-dose or multiple NSAIDs [see Warnings and Precautions ( 5.2)].
Ganciclovir · 7 minor + 9 total pairs
- Bictegravir/Emtricitabine/Tenofovir minor
- Emtricitabine/Tenofovir minor
- Imipenem/Cilastatin minor
- Probenecid minor
Tenofovir Disoproxil · 14 SPL pairs (broader portfolio than Ganciclovir)
- Acyclovir minor
- Cidofovir minor
- Darunavir minor
- Efavirenz/Emtricitabine/Tenofovir minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.